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Background. Cervical cancer is a potentially preventable disease if appropriate screening and prophylactic strategies are employed.
However, lack of knowledge and awareness can result in underutilization of the preventive strategies. Healthcare professionals
with adequate knowledge play a huge role in inﬂuencing the beliefs and practices of the general public in a positive way. We
assessed the knowledge, attitudes, and practices of cervical cancer and screening amongst female healthcare professionals at King
Fahad Medical City (KFMC), Saudi Arabia.Methods. We conducted a cross-sectional study on female healthcare professionals at
KFMC. Data were collected using a predesigned, tested, and self-administered questionnaire. )e questionnaire included speciﬁc
sections to test the participants’ knowledge, attitude, and practices related to cervical cancer and its screening. Data analysis was
done using descriptive statistics. Results. Data from 395 participants were included in the ﬁnal analysis. )e majority of the study
participants were nurses (n� 261, 66.1%). )e mean age of the participants was 34.7 years and 239 (60.5%) participants were
married. Only 16 (4.0%) participants appeared to have good level knowledge of cervical cancer (in terms of risk factors, vul-
nerability, signs and symptoms, ways of prevention, and ways of screening) and 58 (14.7%) participants had fair level knowledge. A
total of 343 (86.8%) participants believed that Pap smear test is a useful test for the detection of cervical cancer and 103 (26.2%)
participants had undergone Pap smear testing. Conclusions. Our study population showed poor knowledge of cervical cancer as a
disease. )e participants had a fair knowledge of Pap smear testing, but only a quarter of the cohort had undergone testing
themselves. )is study highlights the need for formal educational programs for the healthcare workers at KFMC speciﬁcally to
improve their knowledge regarding the risk factors and early signs and symptoms of cervical cancer.
1. Background
Cervical cancer is the fourth most common cancer and also
the fourth leading cause of cancer-related deaths in women
globally [1]. In Saudi Arabia, cervical cancer is the eighth
most common cancer amongst women in the 45- to 59-year
age group and accounts to 2.2% of all cancers [2]. According
to the fact sheet of human papillomavirus (HPV)
information center (2018), it is estimated that, every year,
316 women are diagnosed with cervical cancer and 158 die as
a result of the disease in Saudi Arabia [3]. Several common
risk factors recognized to be associated with cervical cancer
worldwide include sexually transmitted diseases (mainly
HPV and others human immunodeﬁciency virus, herpes
simplex virus), reproductive and sexual factors (multiple
sexual partners, early age at the ﬁrst sexual intercourse, early
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age at ﬁrst delivery, parity, and oral contraceptive pills),
behavioral factors (smoking and obesity), and host factors
(genetic sensitivity) [4]. Abnormal vaginal bleeding, foul-
smelling vaginal discharge, and contact bleeding are rec-
ognized as the major signs of cervical cancer, and in many
cases, women with cervical cancer report no symptoms.
Almost all cervical cancers are caused by HPV and,
therefore, are largely preventable [5]. Over the past several
decades, the incidence of cervical cancer has decreased in
developed countries [6, 7]. )is is mainly attributed to in-
creased awareness and more eﬀective screening and pre-
vention strategies employed in these countries [8, 9]. In
addition, the HPV vaccine has contributed to a decline in the
incidence rate of cervical cancer [10]. )ree types of tests are
currently available and are widely used for the screening of
cervical cancer. )ese include tests for HPV, cytology-based
Papanicolaou test (Pap test), and unaided visual inspection
with acetic acid (VIA) [11]. However, public awareness of
these tests especially in developing countries is limited [12].
HPV 16 and 18 are the most common subtypes of HPV
causing cervical cancer and are responsible for most of the
cervical cancers worldwide [5]. )e association of cervical
cancer and HPV infection implies that cervical cancer can be
prevented by HPV vaccination. Consequently, HPV vac-
cines have been developed [13]. In Saudi Arabia, two vac-
cinations against HPV, bivalent vaccine (Cervarix) and
quadrivalent vaccine (Gardasil) were approved in the year
2010 for females between the ages of 11 and 26 years.
While all these developments in the prevention and
screening of cervical cancer are taking place, it is imperative
that the beneﬁts are utilized by all women including those
living in the developing countries. Having good knowledge
and awareness will help in ensuring that the disease burden
does not increase. One concerning aspect is that most pa-
tients with cervical cancer in Saudi Arabia present at ad-
vanced stages leading to adverse outcomes [14]. Moreover, it
has been found that the cost of treating late-stage cervical
cancer is substantially higher than that of early-stage cancer
[15]. Screening helps in the detection of cancer at an early
stage when it can be treated more eﬀectively. )e late
presentation of patients with cervical cancer in Saudi Arabia
could be due to lack of knowledge and awareness leading to
inadequate screening virtually nonexistent screening
mechanisms for early detection [14]. Moreover, the decision
to undergo screening highly depends on the healthcare
professionals involved as well as the patient [16]. As per the
results of World Health Survey Plus conducted in 2008/
2009, only 7.6% of women in the 25- to 49-year age group in
Saudi Arabia had a Pap smear test done, thus emphasizing
the need to spread awareness amongst women [17].
Prognosis can be improved if screening is embraced and
widely employed. For this, it is important that the healthcare
workers are educated and well aware so that they can in-
ﬂuence the beliefs and actions of the general public. Many
studies have been conducted in other developing countries
to gauge the knowledge and awareness about cervical cancer
and to study the extent of utilization of the screening
methods [12, 18–22]. In Saudi Arabia, although a number of
studies have been conducted to assess the knowledge and
practices of cervical cancer screening in the general pop-
ulation, especially in young girls, studies on healthcare staﬀ
have been few [23–25]. Healthcare facilities are available free
of cost in Saudi Arabia and it is important that these facilities
are utilized well, which can help in improving the general
health status of the nation. Healthcare workers can play a
central role in raising awareness of the general public, and
therefore, their knowledge needs to be assessed and updated
on a regular basis. In addition, in Middle Eastern countries,
in particular patients seeking medical care prefer to have
women as their caregivers with several studies providing
traditional and religious beliefs as the main reason. Women
are most likely to feel comfortable to talk about their
symptoms with a female only. Even female healthcare
providers are hesitant to talk about these issues with male
physicians.
We, therefore, conducted this study to assess the
knowledge, attitudes, and practices towards cervical cancer
and screening amongst female healthcare professionals at
King Fahad Medical City (KFMC), a tertiary hospital in
Riyadh, Saudi Arabia.
2. Methods
2.1. Study Design and Data Collection. We conducted a
cross-sectional study at KFMC in 2018.)e study population
included female healthcare workers with at least one year of
clinical experience, including physicians, nurses, and allied
health staﬀ. )e questionnaire was developed from pre-
viously published studies after an in-depth literature review
[15–21] and then validated through experts. As per the
guidelines, a committee of 2 experts each in research
methodology, obstetrics and gynecology, and oncology
further conﬁrmed the validity of the questionnaire before the
pilot study. Eight questions related to signs and symptoms
were modiﬁed, and 5 were deleted as they were either not
applicable to healthcare workers or not related to this topic
as per the expert comments. After that, pilot testing was
done on the preﬁnal version with 70 participants to assess
the clarity of the questionnaire. Results of the pilot and the
current study showed that Cronbach’s alpha was >0.70.
)e study population was stratiﬁed according to their
professions into three groups: physicians, nurses, and allied
healthcare workers.
To ensure appropriate and equal representation from
each group of healthcare professionals, proportionate
samplingmethod according to the profession was adopted to
derive a sample with equal representation 4 :1 :1. 260 nurses
(out of 2400), 65 physicians (out of 600), and 65 allied
healthcare workers (out of 700) were selected and
approached on a random basis from each hospital/center/
administration at KFMC. )e total sample size was de-
termined to be 390.
)e study participants were randomly selected from each
profession. A survey cover sheet explaining the study was
attached to the questionnaire and the ones who signed it
went to the next step of questionnaire completion. Subject
identiﬁers were not used in the questionnaire, and hence,
conﬁdentiality was maintained. A trained research assistant
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enrolled voluntarily willing participants who ﬁlled in the
questionnaire and returned it.
)e questionnaire was designed to include all information
such as sociodemographic characteristics, knowledge, atti-
tude, and practice of cervical cancer screening.
Participants’ knowledge of cervical cancer was assessed
by listing questions related to risk factors, number of sexual
partners, early sexual intercourse, HPV infection, cigarette
smoking, and other vulnerable factors in women. Questions
under the ﬁve items asking about risk factors, vulnerability,
signs and symptoms, prevention, and ways of screening for
cervical cancer were also included.
For each item, the participants were asked to choose one
of the three options: “Yes,” “No,” or “Don’t know.”
)e scale was then dichotomized such that “Yes” was
considered as 1 and No/Don’t know as 0. A total knowledge
score for all the items was computed by adding up (maxi-
mum score of 20). )e total score was then categorized as
poor knowledge (score of 0–4), fair knowledge (score of
5–10), and good knowledge (10–20).
Participants’ attitude was assessed by asking them to rate
each of the following statements on a 5-point Likert scale: (1)
carcinoma of the cervix is highly prevalent and is a leading
cause of deaths amongst all malignancies in Saudi Arabia; (2)
any young woman including you can acquire cervical carci-
noma; (3) carcinoma of the cervix cannot be transmitted from
one person to another; (4) screening helps in prevention of
carcinoma of the cervix; (5) screening causes no harm to the
client; (6) screening for cervical cancer is not expensive; and (7)
if screening is free and causes no harm, will you screen?
Respondents were asked to choose one of the following
options for each of the statements listed above: “strongly
agree,” “agree,” “neither agree nor disagree,” “disagree,” or
“strongly disagree.” For ease of presenting results, responses
for “strongly agree” and “agree” and for “disagree” and
“strongly disagree” were combined.
Participants’ practices were assessed by asking speciﬁc
questions about practices regarding cervical cancer screening.
Respondents were asked whether they had heard of Pap smear
test and whether they believe it is a useful tool for early de-
tection of cervical cancer. )ey were further asked whether
they had undergone Pap smear testing, at what interval they get
it done, steps to be taken if any abnormality was found in Pap
smear test, and reasons if they had not undergone Pap smear.
)e questionnaire also enquired about other details of Pap
smear testing such as the best time for doing the test, who
should do it (doctor/trained nurse), how it is done, and beneﬁts
of the test. Participants were asked whether they believe un-
dergoing Pap smear testing is a good practice and also whether
they believe it is a painful test. Finally, they were asked whether
they were aware that HPV vaccination is done in their hospital
and whether they had been vaccinated for HPV.
)e study was approved by the ethical committee at the
KFMC, and informed consent was obtained from each
participant before enrolment.
2.2. Statistical Analysis. Demographic characteristics,
knowledge, attitude, and practice of cervical cancer
screening were described using descriptive statistics in-
cluding percentages, frequencies, mean, median, standard
deviation (SD), and interquartile range (IQR). All analyses
were conducted using the software STATA version 12.
3. Results
3.1. Sociodemographic Characteristics. Of the 420 ques-
tionnaires that were distributed, 395 (94%) were returned
and included in the analysis. )e mean age (SD) of the
participants was 34.7 (8.3) years. A total of 261 (66.1%)
respondents were nurses, 63 (16.0%) respondents were
physicians, and the remaining 71 (18.0%) respondents in-
cluded pharmacists, dieticians, technicians, health educa-
tors, physiotherapists, and therapists. About 60% of the
respondents were married. Nine (2.3%) participants re-
ported having history of cervical cancer (Table 1).
3.2. Participants’ Knowledge about Cervical Cancer. Many of
the participants were not knowledgeable about cervical
cancer. For example, only 8.9% of the sample knew that
multiple sexual partners placed a woman at risk for cervical
cancer. Women older than 50 years of age are at higher risk,
yet only 8.6% of the sample had that knowledge. In advanced
stages of cervical cancer, sign and symptoms a woman may
experience are vaginal bleeding, foul-smelling vaginal dis-
charge, and contact bleeding. However, a majority of the
participants were lacking knowledge (93%, 92%, and 87%),
respectively. As for preventing cervical cancer, 90% of the
participants were unaware of the major behaviors one could
do or avoid to prevent cervical cancer. Lastly, a majority of
the participants did not have knowledge about the diﬀerent
ways of screening for cervical cancer (Table 2).
3.3. Participants’ Attitudes towards Cervical Cancer. )e
majority of participants showed disagreement for all the
statements in this section. More than three-fourths of the
participants (84.8%) disagreed with the statement “screening
helps in prevention of carcinoma of the cervix”. Participants’
responses on the various statements that were designed to test
their attitude towards cervical cancer are listed in Table 3.
Overall, only 15 (3.8%) respondents agreed that they would
have screening done if it was free and caused no harm.
3.4. Practice and Knowledge of Cervical Cancer Screening.
Although 343 (86.8%) participants believed that Pap smear
test is a useful test for detection of cervical cancer, only 103
(26.2%) participants had undergone Pap smear testing.
Further, 18.7%, 43.8%, and 29.6% of the participants believed
that Pap smear test should be started at the age of 20 years, 30
years, and after menopause, respectively. Sixty-three percent
of the respondents agreed that the best time for a Pap smear
test is a week after period, and 76.2% believed that Pap smear
testing should be done by a doctor. Also, 78.9% of the re-
spondents agreed that further tests should be done if any
abnormality is detected in Pap smear test. Only 56 (14.2%)
respondents were aware that HPV vaccination is available at
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KFMC and 22 (5.6%) had been vaccinated for HPV. Table 4
presents the results of participants’ responses to questions on
knowledge and practice of cervical cancer screening.
Table 5 shows the relation of the total score for
knowledge about cervical cancer (categorical) with de-
mographic variables.
)e total scale score was signiﬁcantly negatively corre-
lated with age (p value� 0.002) and the total number of years
of experience (p value� 0.004). When we used logistic re-
gression with binary variable (fair-good knowledge� 1 and
poor� 0) as a dependent variable and categorical age (≤30
years vs. >30 years) as explanatory, younger age was sig-
niﬁcantly associated with the higher odds of having fair to
good knowledge odds ratios (OR� 2.22, 95% CI (1.31–3.78).
However, when categorized, the years of experience (<10
years vs. ≥10 years) did not stand signiﬁcant (Table 5).
4. Discussion
Progress in the understanding of cervical cancer has helped
recognize its preventable nature [5]. It is well established that
HPV vaccination and adequate screening can reduce the
burden of the disease to a great extent [6, 7]. For eﬀective
screening and prophylaxis, it is of utmost importance to
understand the knowledge, perceptions, and beliefs of the
population especially that of the healthcare staﬀ as they
constitute an important source of propagation of health-
related information. Many studies conducted in the de-
veloping countries have shed light on the level of un-
derstanding and knowledge of the population, which could
provide useful information to the healthcare systems to
develop appropriate educational strategies [19–21].
Our cohort scored very poorly on the knowledge score,
which is quite alarming as basic level of knowledge about
common diseases is expected from the healthcare staﬀ.
Adequate knowledge is an important determinant of positive
attitude and because our study population did not have the
knowledge, their attitude and beliefs were also concerning.
On the other hand, participants’ knowledge about the
screening of cervical cancer was fairly good. Most re-
spondents believed that Pap smear is a useful tool for early
detection of cervical cancer. )ey also seemed to have a fair
knowledge about certain aspects of Pap smear testing such as
timing of doing Pap smear, action to be taken if the Pap test
results are positive, and so on.
In a study conducted on medical students in Al-Ahsa,
about ﬁfty percent of the study participants were aware of
the early signs and symptoms and risk factors of cervical
cancer [26]. )e better knowledge of these students com-
pared to our cohort can be explained by the fact that these
students, especially those in the ﬁnal year, must have been
taught about cervical cancer as a part of their curriculum
recently and therefore were more informed about the dis-
ease. )is implies is that medical students are not educated
about cervical cancer in any depth. )erefore, they are most
likely not informed prior to practice. It reﬂects that there are
no continuing medical education activities regarding cer-
vical cancer screening and prevention for healthcare
Table 1: Participants’ sociodemographic characteristics.
Variables Mean (SD)/median(IQR)a
Age∗ 34.7 (8.3)
Experience in years∗ 10 (6–16)
Age at marriage∗ (n� 252) 26.2 (4.4)
Number of
pregnancies∗ (n� 252) 2 (1–3)
Designation n (%)b
Physician 63 (16.0)
Nurse 261 (66.1)
Pharmacist 5 (1.3)
Dietician 3 (0.8)
Technician 23 (5.8)
Health educator 1 (0.3)
Physiotherapists 7 (1.8)
)erapist 21 (5.3)
Others 11 (2.8)
Hospital/center/department∗
Comprehensive Cancer Center 16 (4.1)
National Neurosciences Institute 9 (2.3)
King Salman Heart Center 19 (4.8)
Obesity Endocrine and Metabolic
Center 1 (0.3)
Women’s Specialized Hospital 49 (12.4)
Children’s Specialized Hospital 135 (34.2)
Rehabilitation Hospital 33 (8.4)
Main Hospital 101 (25.6)
Others 28 (7.1)
Level of education∗
High school or diploma 69 (17.5)
Bachelor 272 (68.9)
Master or PhD 52 (13.2)
Marital status∗
Single 143 (36.2)
Married 239 (60.5)
Divorced 11 (2.8)
Widow 1 (0.3)
Single marriage (monogamy)∗ (n� 252) 223 (88.5)
Number of children (parity, n� 252)∗
0 41 (16.3)
1–3 166 (65.9)>3 31 (12.3)
Number of abortions∗ (n� 252)
0 157 (62.3)
1–2 63 (25.0)>2 10 (4.0)
One or more stillbirths∗ (n� 252) 18 (7.1)
Any history of cervical cancer∗ 9 (2.3)
First-degree relatives’ history of
cervical cancer∗ 15 (3.8)
Second-degree relatives or friend
with history of cervical∗ 12 (3.0)
aMean (standard deviation (SD))/median (interquartile range (IQR)).
bFrequency (percentage). ∗Data are missing in participants’ age
(n � 30), years of experience (24), age at marriage (163), number of
pregnancies (150), hospital/center/department (4), level of education
(2), marital status (1), single marriage (163), number of children (152),
number of abortions (163), one or more stillbirths (164), history of
cervical cancer (13), ﬁrst-degree relatives’ history of cervical cancer
(19), and second-degree relatives or friend’s history of cervical (31). In
the calculation of percentages (%), the denominators include missing
observations.
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Table 2: Participants’ knowledge about cervical cancer.
Items of the knowledge scale for cervical cancer Frequency (%)a 95% CIb
Risk factors
R1: multiple sexual partners∗ 35 (8.9) 6.2–12.1
R2: early sexual intercourse∗ 57 (14.4) 11.1–18.3
R3: HPV infection (human papillomavirus)∗ 38 (9.6) 6.9–13.0
R4: infection with the human immunodeﬁciency
virus (HIV)∗ 54 (13.7) 10.4–17.5
R5: cigarette smoking∗ 51 (12.9) 9.8–16.6
R6: ever used contraceptive methods∗ 53 (13.4) 10.2–17.2
Vulnerability
V1: women age >50 years∗ 34 (8.6) 6.0–11.8
V2: reproductive age∗ 55 (13.9) 10.7–17.7
V3: both of the above∗ 62 (15.7) 12.3–19.7
Sign and symptoms
S1: vaginal bleeding∗ 27 (6.8) 4.6–9.8
S2: foul-smelling vaginal discharge∗ 29 (7.3) 5.0–10.4
S3: contact bleeding∗ 48 (12.2) 9.1–15.8
Prevention
P1: avoiding multiple sexual partners∗ 30 (7.6) 5.2–10.7
P2: avoiding early sexual intercourse∗ 49 (12.4) 9.3–16.1
P3: screening and treatment∗ 11 (2.8) 1.4–4.9
P4: avoid/quit cigarette smoking∗ 39 (9.9) 7.1–13.2
P5: all of the above∗ 39 (9.9) 7.1–13.2
What are the ways of screening
WS1: Pap smear∗ 17 (4.3) 2.5–6.8
WS2: visual inspection of cervix∗ 25 (6.3) 4.1–9.2
WS3: human papillomavirus DNA testing∗ 42 (10.6) 7.8–14.1
WS4: liquid-based cytology∗ 75 (19.0) 15.2–23.2
WS4: there is no way of screening∗ 31 (7.9) 5.4–11.0
Median (IQR) total score for the knowledge scaleϮ 1 (0–4)
Level of knowledge based on the total score
Poor (score of 0–4) 311 (80.8) 76.5–84.5
Fair (score of 5–10) 58 (15.0) 11.6–18.8
Good (score of 11–20) 16 (4.2) 2.5–6.8
aFrequencies and percentage (%) for the “Yes” responses; percentages are computed with missing observations included in the denominator. b95% conﬁdence
intervals in column 3 for the percentages (%) in column 2. ϮResponses to each item in column 1 were recoded as Yes� 1 and No or Don’t know� 0, and total
score (0–20) was computed, andmedian total score (interquartile range (IQR)) is presented in the table. ∗Data are missing in R1 (for 22 participants), R2 (24),
R3 (20), R4 (41), R5 (29), and R6 (51); V1 (39), V2 (50), and V3 (77); S1 (14), S2 (19), and S3 (24); P1 (23), P2 (29), P3 (19), P5 (29), and P6 (67);WS1 (20),WS2
(35), WS3 (67), WS4 (72), and WS5 (73).
Table 3: Participants’ attitudes towards cervical cancer.
Statements describing attitudes of the participants
towards cervical cancer Agree, n (%) Neither agree nor disagree, n (%) Disagree, n (%)
A1: carcinoma of the cervix is highly prevalent and is
a leading cause of deaths amongst all malignancies in
Saudi Arabia∗ 52 (13.2) 124 (31.4) 210 (53.2)
A2: any young woman including you can acquire
cervical carcinoma∗ 29 (7.3) 48 (12.2) 309 (78.2)
A3: carcinoma of the cervix cannot be transmitted
from one person to another∗ 79 (20.0) 39 (9.9) 265 (67.1)
A4: screening helps in prevention of carcinoma of the
cervix∗ 18 (4.6) 32 (8.1) 335 (84.8)
A5: screening causes no harm to the client∗ 36 (9.1) 41 (10.4) 309 (78.2)
A6: screening for cervical cancer is not expensive∗ 51 (12.9) 108 (27.3) 225 (57.0)
A7: if screening is free and causes no harm, will you
screen?∗ 15 (3.8) 29 (7.3) 342 (86.6)
n (%): frequencies (percentage) of participants; percentages are computed with missing observations included in the denominator. ∗Data are missing in A1
(for 9 participants), A2 (9), A3 (12), A3 (10), A5 (9), A6 (11), and A6 (9).
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Table 4: Practice and knowledge of cervical cancer screening.
Statements for assessing knowledge and practice of
cervical cancer screening Frequency (%)
a 95% CIb
KP1: yes—I have heard of Pap smear test for CCS∗ 335 (84.8) 81.3–88.2
KP2: it is a useful tool for early detection of cervical
cancer∗ 343 (86.8) 83.1–90.0
KP3: age at which Pap smear test be started∗
From birth 1 (0.3) 0.01–1.4
From puberty 23 (5.8) 3.7–8.6
From 20 years 74 (18.7) 15.0–22.9
From 30 years 173 (43.8) 38.8–48.8
After menopause 117 (29.6) 25.2–34.4
KP4: yes—I have undergone Pap smear test∗ 103 (26.2) 21.9–30.9
KP5: if yes to above, interval for Pap smear test∗
Monthly 6 (5.4) 2.0–11.4
Yearly 76 (68.5) 59.0–77.0
After menopause 3 (2.7) 0.5–7.7
Not sure 26 (23.4) 15.9–32.4
KP6: reasons if the test is not done∗
I see no reason for the test 116 (48.5) 42.0–55.0
I am afraid of the procedure 41 (17.2) 12.6–22.5
I am afraid of the bad results 8 (3.4) 1.5–6.5
I do not know whom to consult for undergoing this
test 27 (11.3) 7.6–16.0
Others (including multiple of the above) 47 (19.7) 14.8–25.2
KP7: best time for doing Pap smear test∗
During menstrual ﬂow 12 (3.0) 1.6–5.2
A week after period 249 (63.0) 58.1–67.8
During pregnancy 2 (0.5) 0.06–1.8
During breastfeeding 1 (0.3) 0.0–1.4
Not sure 119 (30.1) 26.0–34.9
KP8: Pap smear test should be done by∗
Doctor 301 (76.2) 71.7–80.3
Trained nurse 29 (7.3) 5.0–10.3
Not sure 29 (7.3) 5.0–10.3
Others (including the 1st two) 25 (6.3) 4.1–9.2
KP9: abnormality in Pap smear test, what should be
done?∗
Leave it to God and pray 2 (0.5) 0.0–1.8
Do some lab tests 312 (78.9) 74.6–82.9
Not sure 40 (10.1) 7.3–13.5
Others 31 (6.3) 4.19.2
KP10: beneﬁts of Pap smear test∗
Early detection of cervical cancer 175 (44.3) 39.3–49.4
Detection of any early abnormal changes in the
cervix 132 (33.4) 28.8–38.3
Not sure 20 (5.1) 3.1–7.7
Above two 59 (14.9) 11.6–18.8
KP11: Pap smear test is painful∗ 156 (39.5) 34.6–44.5
KP12: undergoing Pap smear test is a good practice∗ 324 (82.0) 77.9–85.6
KP13: Pap smear test is done using∗
Transvaginal ultrasound 40 (10.1) 7.3–13.5
Vaginal brushing 224 (56.7) 51.7–61.7
Not sure 89 (22.5) 18.5–27.0
Others 33 (8.4) 5.8–11.5
KP14: human papillomavirus vaccination is available
in our institution∗ 56 (14.2) 10.9–18.1
KP15: I have been vaccinated for human
papillomavirus∗ 22 (5.6) 3.5–8.3
aFrequencies and percentage (%) of participants’ responses; percentages are computed with missing observations included in the denominator. b95%
conﬁdence intervals in column 3 for the percentages (%) in column 2. ∗Data are missing in KP1 (for 2 participants), KP2 (4), KP3 (7), KP4 (2), KP5 (not
applicable or missing: 284), KP6 (not applicable or missing: 156), KP6 (12), KP7 (11), KP9 (10), KP10 (9), KP11 (11), KP12 (9), KP13 (48), and KP14 (47).
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professionals in the region. Moreover, there is a low in-
cidence of cervical cancer in Saudi Arabia due to which the
healthcare professionals come across few cases with cervical
cancer, and therefore, they have inadequate knowledge re-
garding HPV vaccine and other prevention modes [27]. )is
highlights the fact that continued medical education is
imperative to help the healthcare staﬀ to keep abreast of the
facts about important diseases as well as to keep them
updated with the newer developments related to healthcare.
When formal screening programs are not in place,
cervical screening is mostly “opportunistic,” which means
women attending the clinics for other ailments are directed
by the healthcare workers for cervical cancer screening. )is
is mostly done by staﬀ in the gynecological department;
however, if healthcare workers in other specialties also start
referring eligible patients, the number of patients un-
dergoing cervical cancer screening will greatly increase
[23, 28].
Most women in our cohort were young and married
making them most likely sexually active. Although multiple
sexual partners are a risk factor for cervical cancer, we did
not include that personal question to the participants, be-
lieving it to be oﬀensive to the culture in Saudi Arabia. It is
highly recommended to have Pap smear done in women
above 21 years of age [29]. Also, HPV vaccine can be taken
by women until the age of 26 years [30]. Gardasil (quad-
rivalent vaccine eﬀective against HPV types 6, 11, 16, and 18)
and Cervarix (bivalent vaccine eﬀective against HPV types
16 and 18) are the two vaccines approved by the US FDA in
2006 and 2009, respectively [30, 31].)ese are widely used in
western countries, and their use should be encouraged in
developing countries.)ese vaccines were approved in Saudi
Arabia in the year 2010 for females between the ages of 11
and 26 years [13]. Vaccination for HPV could not be in-
cluded in Saudi’s national vaccination programs viewing the
low incidence and higher cost for the health system. )us, it
is presently oﬀered to selected individuals including women
conﬁrmed at risk for HPV infection or who voluntarily want
to be vaccinated [32]. )ese vaccines are available in Saudi
Arabia in select hospitals. KFMC is one such hospital and
young female staﬀ should take advantage of this facility and
protect themselves from HPV infection. From the results of
our study, it appears that most of our staﬀ are not aware that
this vaccine is available within KFMC. )is calls for an
urgent need to plan strategies to educate the staﬀ not only on
the beneﬁts and need of HPV vaccination but also about its
availability within the KFMC facility.
A study was conducted in Riyadh, Saudi Arabia, to
examine whether the educational program had any eﬀect on
female healthcare students in terms of their knowledge
regarding screening and prevention of cervical cancer. )e
results were promising with all scores improving signiﬁ-
cantly after the intervention in the form of educational
program. )is study provides further insight into the ne-
cessity and importance of educational activities, which could
be in the form of lectures using audiovisual aids [24].
Our study has several limitations. Firstly, it was con-
ducted only in one center, and therefore, the results cannot
be generalized to the healthcare workers at other institutions
in Saudi Arabia. Secondly, our sample was composed of a
heterogeneous group of healthcare workers including
physicians, nurses, and allied healthcare workers in various
specialties which may have led to varied knowledge, attitude,
and practices towards the screening. It is sad that healthcare
workers especially nurses and physicians lacked the
knowledge they should have had from their formal
education.
)e study results imply that if women, irrespective of
their profession, do not receive education to increase their
functional knowledge, understanding, and acceptance of
routine cervical cancer screening, then they may not be able
to promote behavior change in themselves, in their patients,
Table 5: Relation of the total score for knowledge about cervical cancer (categoricala) with demographic variables.
Sociodemographic variables
Poor knowledge (score:
0–4)
Fair knowledge (score:
5–10)
Good knowledge (score:
11–20) pvaluesMedian (IQR) Median (IQR) Median (IQR)
Age (≤30 years vs. >30 years) 34 (30–41) 29 (25–37) 35 (28–37.5) 0.002
Age at marriage 26.5 (24–28) 27 (24–29) 26.5 (25.5–28) 0.701
Total experience in years (<10 years vs. ≥10
years) 11 (7–16) 8 (1–13) 10.5 (4–14.5) 0.004
n (%) n (%) n (%)
Level of education
High school or diploma 56 (18.1) 8 (13.8) 4 (25.0) 0.485
Bachelor 216 (69.9) 40 (69.0) 9 (56.3)
Master or PhD 37 (12.0) 10 (17.2) 3 (18.8)
Designation/profession
Nurses 218 (70.1) 31 (53.5) 8 (50.0) 0.030
Physicians 48 (15.4) 11 (19.0) 3 (18.8)
Others 45 (14.5) 16 (27.6) 5 (31.3)
Hospital/center/department
Others 126 (40.9) 20 (34.5) 8 (53.3) 0.139
CSH 104 (33.8) 27 (46.6) 2 (13.3)
Main Hospital 78 (25.3) 11 (19.0) 5 (33.3)
aKnowledge of cervical cancer could not be determined for 10 participants due to missing data for some of the responses.
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or in the general population. First and foremost, the in-
stitution needs to develop a plan to intervene through ed-
ucation for self-care and also encourage them to educate
other women they may encounter in their professional role
or in their personal life. Also, a follow-up study can be
considered to evaluate the usefulness of the educational
program after it is in place at KFMC.
Further studies should be carried out in other hospitals
in Saudi Arabia to understand the gaps in the knowledge and
practice of cervical cancer screening.
5. Conclusion
Cervical cancer is totally preventable. Healthcare providers
should be proactive in promoting women’s health and
preventing disease. )erefore, making sure healthcare
professionals are informed about the beneﬁts of routine
cervical cancer screening and preventive methods will be a
step toward making sure cervical cancer does not increase in
Saudi Arabia.
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